blog.aids.gov — HIV Policy & Programs. Research. New Media.
HIV Policy & Programs. Research. New Media.
The Food and Drug Administration (FDA) wants to talk to people living with HIV (PLWH) and HIV/AIDS advocates. On June 14, under its Patient-Focused Drug Development initiative, FDA will ask PLWH to join an open public discussion about: the impact of HIV on your daily life, experience with currently available therapies to treat HIV, your…
On December 1, World AIDS Day, we remember those we have lost, but also celebrate the remarkable progress made in the global fight against HIV/AIDS. When the first World AIDS Day was observed in 1988, we could not imagine the end of the HIV/AIDS epidemic. For those diagnosed with HIV infection, the future was bleak….
Cross-posted from the FDA Blog World AIDS Day has been observed in the United States on December 1 since 1995. When I look back at early World AIDS Day observances, I remember them as a way of raising awareness of the men, women and children who had no advocates, no representation, no medicines, and practically…
Dr. Lynne Meryl Mofenson, Branch Chief, Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, has received a Samuel J. Heyman Service to America Medal (“Sammie”) for the role she has played in preventing the AIDS epidemic among children by studying ways to prevent mother-to-child transmission…
At the XIX International AIDS Conference (AIDS 2012) in Washington, DC today, Dr. Howard Koh, Assistant Secretary for Health, released a report (PDF 607KB) on the progress made in 2011 by the U.S. Department of Health and Human Services (HHS) in pursuing the goals of the National HIV/AIDS Strategy (NHAS). The report highlights key accomplishments…
The doors to Washington, D.C. open to the world today with the official start of the XIX International AIDS Conference. For the first time in 22 years, the United States welcomes the world’s largest gathering of professionals working in the field of HIV. This affords us the opportunity to rapidly learn about new developments to…
Today (July 16, 2012), the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truvada, taken daily, is to be used for…
Yesterday, colleagues at the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH), and the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) advanced one of the important action items detailed in the Action Plan for the Prevention, Care and Treatment…
